|
| “Characteristics of Patients and Tumors” | “Radiation Group (n = 23)” | “Chemoradiation Group (n = 25)” | p-value |
| Sex | Female | 10 | 17 | 0.793 |
| Male | 13 | 8 | ||
| Age | Age, Mean | 51 | 46 | 0.275 |
| Primary site | Parotid gland | 12 | 19 | 0.394 |
| Submandibular gland | 4 | 1 | ||
| Sublingual gland | 0 | 0 | ||
| Minor salivary gland | 7 | 5 | ||
| T stage | T1 | 2 | 1 | 0.099 |
| T2 | 7 | 10 | ||
| T3 | 10 | 10 | ||
| T4 | 4 | 4 | ||
| N stage | Node negative | 18 | 21 | 0.332 |
| Node positive | 5 | 4 | ||
| Tumor stage | II | 8 | 8 | 0.103 |
| III | 9 | 12 | ||
| IV a | 6 | 5 | ||
| Histologic type | Mucoepidermoid carcinoma | 6 | 5 | 0.22 |
| Salivary duct carcinoma | 0 | 3 | ||
| myoepithelial carcinoma | 0 | 1 | ||
| Adenoid cystic carcinoma | 14 | 14 | ||
| Adenocarcinoma | 2 | 3 | ||
| High-risk features | Positive surgical margin | 12 | 15 | 0.32 |
| Close surgical margin | 6 | 7 | ||
| Negative margin |
|
| ||
| Perineural invasion | 14 | 16 | 0.147 | |
| High-grade Histologic characteristics | 12 | 13 | 0.09 | |
| Any of the above | 23 | 25 |
|